drugset / Trial / NCT00673075
The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being done to see if the blood pressure lowering effect of an approved drug nebivolol is comparable to that of another approved drug carvedilol for the treatment of hypertension in patients who have coronary artery disease.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carvedilol | Other / unclassified | 12.5 mg | Oral |
| Comparator | Carvedilol | Other / unclassified | 25 mg | Oral |
| Comparator | Carvedilol | Other / unclassified | 50 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 5 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 10 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 20 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 40 mg | Oral |